molgramostim: Clinical Trials

4 trials of molgramostim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow molgramostim: new trials by email Literature Review of molgramostim trials Research Report on molgramostim

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
Molgramostim - Autoimmune Pulmonary Alveolar Proteinosis
Phase 3RecruitingSavara Inc.52025-10-222026-02-19
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Molgramostim, Placebo, Molgramostim Open-label - Autoimmune Pulmonary Alveolar Proteinosis
Phase 3Active not recruitingSavara Inc.1642021-05-192026-11-18
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
Molgramostim - Autoimmune Pulmonary Alveolar Proteinosis
Phase 3TerminatedSavara Inc.602018-04-162024-07-03
Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients
CSF470 vaccine, BCG, Molgramostim, interferon alpha 2b - Cutaneous Melanoma
Phase 2 / Phase 3UnknownLaboratorio Pablo Cassara S.R.L.1082009-04-012015-09-02

Conditions studied

Pulmonary Alveolar Proteinosis, Acquired (3)  ·  Melanoma (1)  ·  Pulmonary Alveolar Proteinosis (1)

Sponsors

Savara Inc. (3)  ·  Laboratorio Pablo Cassara S.R.L. (1)

Countries

Germany (3)  ·  France (2)  ·  Greece (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Israel (1)  ·  Japan (1)

Top investigators

Bruce Trapnell, MD (1)  ·  Francesco Bonella, Prof. (1)  ·  Matthias Griese, MD, (1)

Results publications

PMID 28620382, PMID 29774030, PMID 40834301

NIH funding

2017 (1)